Original language | English |
---|---|
Pages (from-to) | 1-4 |
Number of pages | 4 |
Journal | Expert Review of Clinical Pharmacology |
Volume | 2 |
Issue number | 1 |
DOIs | |
State | Published - 2009 |
Bibliographical note
Funding Information:Our US Patent No. 7,438,904 and PCT Int. Appl. WO/2008/008358 cover the above-discussed high-activity mutants of human BChE and the thermostable mutants of CocE, respectively. Financial support from the National Institute on Drug Abuse (NIDA) of NIH grants R01 DA013930, R01 DA021416, and R01 DA025100) are gratefully acknowledged. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics (all)
- Pharmacology (medical)